Stella Martomo

859 total citations
24 papers, 683 citations indexed

About

Stella Martomo is a scholar working on Oncology, Immunology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Stella Martomo has authored 24 papers receiving a total of 683 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 14 papers in Immunology and 8 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Stella Martomo's work include CAR-T cell therapy research (14 papers), Monoclonal and Polyclonal Antibodies Research (8 papers) and Immune Cell Function and Interaction (8 papers). Stella Martomo is often cited by papers focused on CAR-T cell therapy research (14 papers), Monoclonal and Polyclonal Antibodies Research (8 papers) and Immune Cell Function and Interaction (8 papers). Stella Martomo collaborates with scholars based in United States, Japan and Netherlands. Stella Martomo's co-authors include Patricia J. Gearhart, William Yang, Fumio Hanaoka, Roger Woodgate, Alexandra Vaisman, Masayuki Yokoi, Christopher K. Mathews, Huseyin Saribasak, Teresa Wilson and Akira Yasui and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Experimental Medicine and Journal of Clinical Oncology.

In The Last Decade

Stella Martomo

23 papers receiving 676 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stella Martomo United States 10 448 345 125 123 83 24 683
Huseyin Saribasak United States 13 510 1.1× 349 1.0× 99 0.8× 58 0.5× 108 1.3× 18 828
Annie De Smet France 10 530 1.2× 259 0.8× 100 0.8× 66 0.5× 114 1.4× 13 708
Diana Ronai United States 10 341 0.8× 323 0.9× 56 0.4× 68 0.6× 42 0.5× 14 601
Quentin Guéranger France 9 490 1.1× 218 0.6× 88 0.7× 62 0.5× 186 2.2× 9 675
Subhra Chaudhuri United States 8 392 0.9× 194 0.6× 123 1.0× 51 0.4× 51 0.6× 13 566
Fraser McBlane United States 12 600 1.3× 309 0.9× 146 1.2× 40 0.3× 56 0.7× 17 852
Erin K. Linehan United States 12 427 1.0× 360 1.0× 122 1.0× 60 0.5× 39 0.5× 19 635
David B. Winter United States 13 659 1.5× 472 1.4× 88 0.7× 218 1.8× 137 1.7× 22 987
Eva Besmer United States 9 492 1.1× 598 1.7× 127 1.0× 64 0.5× 52 0.6× 9 968
Hirotaka Nakahashi Japan 8 733 1.6× 228 0.7× 106 0.8× 79 0.6× 92 1.1× 20 952

Countries citing papers authored by Stella Martomo

Since Specialization
Citations

This map shows the geographic impact of Stella Martomo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stella Martomo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stella Martomo more than expected).

Fields of papers citing papers by Stella Martomo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stella Martomo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stella Martomo. The network helps show where Stella Martomo may publish in the future.

Co-authorship network of co-authors of Stella Martomo

This figure shows the co-authorship network connecting the top 25 collaborators of Stella Martomo. A scholar is included among the top collaborators of Stella Martomo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stella Martomo. Stella Martomo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Sergeeva, Oksana A., Eric M. Tam, Guixian Jin, et al.. (2023). 1386 EVOLVE-106, a T cell engager with integrated CD2 costimulation targeting B7-H4, is a precision therapy for estrogen and Her2 receptor low breast cancers. SHILAP Revista de lepidopterología. A1541–A1541. 2 indexed citations
3.
Tam, Eric M., Guixian Jin, Oksana A. Sergeeva, et al.. (2023). 1392 EVOLVE-104, a novel ULBP2-targeted T cell engager that integrates CD2 costimulation for the treatment of basal and squamous lineage tumors. SHILAP Revista de lepidopterología. A1547–A1547. 1 indexed citations
4.
5.
Martomo, Stella & Jeegar Patel. (2022). Evaluation of the clinical molecule anti-human-PD-L1/IL-15 KD033 in the human-PD-1/PD-L1-expressing murine model demonstrates PD-L1 targeting of IL-15 in vivo. Cancer Immunology Immunotherapy. 72(6). 1941–1950. 3 indexed citations
6.
7.
Martomo, Stella, et al.. (2021). 45P A novel bi-functional IL15 cytokine fusion antibody selected to kill B7-H4 positive tumor cells. Annals of Oncology. 32. S1391–S1391. 4 indexed citations
8.
Luke, Jason J., Anthony J. Olszanski, Igor Puzanov, et al.. (2021). 512 Phase I dose escalation of KD033, a PDL1-IL15 bispecific molecule, in metastatic and advanced solid tumors. SHILAP Revista de lepidopterología. A543–A543. 1 indexed citations
9.
Martomo, Stella, et al.. (2020). Single-Dose Anti–PD-L1/IL-15 Fusion Protein KD033 Generates Synergistic Antitumor Immunity with Robust Tumor-Immune Gene Signatures and Memory Responses. Molecular Cancer Therapeutics. 20(2). 347–356. 22 indexed citations
10.
Lu, Dan, et al.. (2020). 573 A novel human anti-PD1/IL15 bi-functional protein with robust anti-tumor activity and low systemic toxicity. SHILAP Revista de lepidopterología. A344.2–A344. 1 indexed citations
11.
12.
Martomo, Stella, et al.. (2019). Anti-PDL1/IL-15 fusion protein increases rare effector cells in cynomolgus monkeys and mice. Annals of Oncology. 30. xi4–xi4. 1 indexed citations
13.
Wu, Yan, Zhaojing Zhong, Stella Martomo, et al.. (2015). Abstract C173: Anti-PD-L1 antibody-based IL-15 immunocytokine has enhanced antitumor immunity. Molecular Cancer Therapeutics. 14(12_Supplement_2). C173–C173. 1 indexed citations
14.
Maul, Robert W., Huseyin Saribasak, Stella Martomo, et al.. (2010). Uracil residues dependent on the deaminase AID in immunoglobulin gene variable and switch regions. Nature Immunology. 12(1). 70–76. 97 indexed citations
15.
Martomo, Stella, Huseyin Saribasak, Masayuki Yokoi, Fumio Hanaoka, & Patricia J. Gearhart. (2008). Reevaluation of the role of DNA polymerase θ in somatic hypermutation of immunoglobulin genes. DNA repair. 7(9). 1603–1608. 39 indexed citations
16.
Martomo, Stella, William Yang, Alexandra Vaisman, et al.. (2006). Normal hypermutation in antibody genes from congenic mice defective for DNA polymerase ι. DNA repair. 5(3). 392–398. 29 indexed citations
17.
Martomo, Stella & Patricia J. Gearhart. (2006). Somatic hypermutation: subverted DNA repair. Current Opinion in Immunology. 18(3). 243–248. 31 indexed citations
18.
Martomo, Stella, Dongtao Fu, William Yang, Nikhil S. Joshi, & Patricia J. Gearhart. (2005). Deoxyuridine Is Generated Preferentially in the Nontranscribed Strand of DNA from Cells Expressing Activation-Induced Cytidine Deaminase. The Journal of Immunology. 174(12). 7787–7791. 22 indexed citations
19.
Wilson, Teresa, Alexandra Vaisman, Stella Martomo, et al.. (2005). MSH2–MSH6 stimulates DNA polymerase η, suggesting a role for A:T mutations in antibody genes. The Journal of Experimental Medicine. 201(4). 637–645. 146 indexed citations
20.
Martomo, Stella & Christopher K. Mathews. (2002). Effects of biological DNA precursor pool asymmetry upon accuracy of DNA replication in vitro. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 499(2). 197–211. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Huseyin Saribasak Breakdown of academic impact, for papers by Annie De Smet Breakdown of academic impact, for papers by Diana Ronai Breakdown of academic impact, for papers by Quentin Guéranger Breakdown of academic impact, for papers by Subhra Chaudhuri Breakdown of academic impact, for papers by Fraser McBlane Breakdown of academic impact, for papers by Erin K. Linehan Breakdown of academic impact, for papers by David B. Winter Breakdown of academic impact, for papers by Eva Besmer Breakdown of academic impact, for papers by Hirotaka Nakahashi
Rankless by CCL
2026